Obesity Medicine

Welcome Message

Dear Participants,

On behalf of the Organizing Committee, it is our great pleasure to welcome you all to the 20th International Conference on Obesity Medicine, to be held on January 26–27, 2026, in Rome, Italy.

This milestone event brings together leading researchers, clinicians, public health experts, and policymakers from around the world to share the latest advances, exchange ideas, and discuss innovative strategies in the prevention, management, and treatment of obesity.

We are confident that the scientific sessions, keynote presentations, and interactive discussions will inspire collaboration and foster meaningful connections among participants. Beyond the conference halls, we hope you will also take the opportunity to explore the historic beauty and rich culture of Rome — a city that perfectly blends tradition with innovation.

Once again, welcome to Rome and to the 20th International Conference on Obesity Medicine. We look forward to an engaging, enlightening, and memorable experience for all.

Warm regards,
The Organizing Committee
20th International Conference on Obesity Medicine
January 26–27, 2026 | Rome, Italy

About the Conference

The 20th International Conference on Obesity Medicine will be held on January 26–27, 2026, in Rome, Italy, under the theme “Innovations and Advances in Obesity Prevention and Treatment Strategies.” This conference will bring together leading researchers, clinicians, surgeons, nutrition experts, public health professionals, and policymakers from around the world to discuss the latest developments and emerging trends in obesity medicine.

The meeting aims to create a global platform for knowledge exchange, focusing on the scientific, clinical, and societal aspects of obesity prevention, diagnosis, and treatment. Participants will gain insights into cutting-edge research, modern therapeutic techniques, lifestyle interventions, and community-based prevention approaches. The event will also explore advances in pharmacological therapies, bariatric surgery, metabolic research, and evidence-based clinical practices that are transforming obesity care.

Through keynote lectures, panel discussions, poster sessions, and networking opportunities, attendees will have the chance to share expertise, build collaborations, and contribute to shaping future directions in obesity medicine. Hosting this prestigious event in Rome offers an inspiring setting for professional dialogue and cultural engagement, making it an unmissable opportunity for all those committed to improving global health and combating the growing burden of obesity.

Why to Attend

The 20th International Conference on Obesity Medicine offers a unique opportunity to connect with global experts dedicated to advancing the understanding, prevention, and management of obesity. This prestigious event in Rome, Italy, will serve as an international platform for clinicians, researchers, dietitians, endocrinologists, and healthcare professionals to exchange innovative ideas, present groundbreaking research, and explore emerging therapeutic strategies.

• Gain insights into the latest innovations and research in obesity prevention and treatment.
• Learn about advanced clinical practices and modern therapeutic approaches in obesity medicine.
• Explore developments in nutrition, pharmacology, metabolic health, and bariatric surgery.
• Interact with leading researchers, clinicians, dietitians, and public health professionals from around the world.
• Participate in keynote sessions, workshops, and panel discussions led by global experts.
• Present your research findings through oral and poster sessions for international recognition.
• Build collaborative networks for future research, clinical trials, and academic partnerships.
• Discover evidence-based strategies for long-term obesity management and prevention.
• Gain continuing professional development and enhance your global knowledge base.
• Experience Rome’s scientific, cultural, and historical environment while engaging in professional dialogue

Target Audience

• Obesity medicine specialists and healthcare practitioners
• Endocrinologists and diabetologists
• Nutritionists and dietitians
• Bariatric and metabolic surgeons
• Clinical researchers and academic scientists
• Pediatric and adolescent medicine professionals
• Public health experts and epidemiologists
• Physical therapists and rehabilitation specialists
• Pharmaceutical and biotechnology industry representatives
• Behavioral and lifestyle medicine professionals
• Fitness and wellness experts
• Medical students, postgraduate trainees, and early-career researchers
• Hospital administrators and healthcare policymakers
• Health educators and community health workers
• Representatives from obesity associations and research organizations

Sessions and Tracks

Track 01: Obesity & Associated Health Disorders

Obesity is a complex, multifactorial disease that significantly contributes to a wide range of health disorders. The excessive accumulation of body fat disrupts normal metabolic processes, causing systemic inflammation, insulin resistance, and hormonal imbalances. These disruptions are strongly associated with type 2 diabetes, cardiovascular diseases, non-alcoholic fatty liver disease, and certain types of cancer. Obesity also exacerbates musculoskeletal problems, including osteoarthritis, spinal disorders, and chronic pain syndromes, which affect quality of life and mobility. Furthermore, obesity is linked to psychological disorders such as depression, anxiety, and low self-esteem, creating a bidirectional relationship that complicates treatment strategies. Early diagnosis and intervention are critical to managing obesity and preventing the onset of associated comorbidities. Comprehensive management strategies involve a combination of lifestyle modifications, pharmacotherapy, surgical interventions, and behavioral therapy. In addition, public health policies focusing on obesity prevention and education play a significant role in mitigating these health risks. Research continues to explore the molecular mechanisms behind obesity-related disorders, aiming to develop targeted therapies that improve patient outcomes. Understanding the link between obesity and health disorders is vital for healthcare providers to design personalized, multidisciplinary approaches for treatment and prevention.

Track 02: Gynaecology & Obstetrics

Obesity significantly impacts gynecological and obstetric health, affecting fertility, pregnancy outcomes, and long-term maternal well-being. Excess body weight disrupts hormonal balance, leading to irregular menstrual cycles, polycystic ovary syndrome, and impaired ovulation, which can reduce fertility in women of reproductive age. During pregnancy, obesity increases the risk of gestational diabetes, preeclampsia, hypertension, and complications during labor and delivery. Additionally, obese mothers are more likely to require cesarean sections, and their infants have a higher risk of macrosomia, congenital abnormalities, and neonatal intensive care admissions. Postpartum, obesity can affect lactation, wound healing, and the risk of developing long-term metabolic conditions. Managing obesity before, during, and after pregnancy is crucial to minimizing maternal and fetal complications. Interventions include dietary guidance, physical activity programs, behavioral therapy, and careful medical monitoring. Healthcare professionals must adopt a multidisciplinary approach involving obstetricians, endocrinologists, dietitians, and mental health specialists to optimize outcomes for both mother and child. Research in this field focuses on understanding how maternal obesity impacts fetal development and identifying strategies to reduce adverse outcomes while promoting healthy maternal weight management.

Track 03: Obesity in Women

Obesity in women presents unique challenges due to biological, hormonal, and societal factors. Women are more prone to certain fat distribution patterns, such as central and visceral obesity, which increases the risk of metabolic syndrome, insulin resistance, and cardiovascular diseases. Hormonal changes related to menstruation, pregnancy, and menopause significantly influence body weight and fat distribution. Women with obesity are at increased risk for infertility, polycystic ovary syndrome, and complications during pregnancy and childbirth. Psychosocial factors, including societal pressure, stigma, and body image issues, further complicate weight management. Effective treatment strategies require a gender-sensitive approach that incorporates nutritional guidance, behavioral counseling, exercise, pharmacotherapy, and surgical options when appropriate. Public health programs targeting women’s health should focus on education, early intervention, and empowerment to promote sustainable weight management. Research into female-specific pathways of obesity and metabolic dysfunction continues to provide insights into personalized therapies that address the physiological and psychological aspects of obesity in women. Understanding these nuances is essential for healthcare providers to offer effective, individualized care for women living with obesity.

Track 04: Bariatric Surgery

Bariatric surgery is a highly effective treatment for severe obesity, especially for individuals who have not achieved sustainable weight loss through lifestyle interventions or pharmacotherapy. This surgical approach encompasses procedures such as gastric bypass, sleeve gastrectomy, adjustable gastric banding, and biliopancreatic diversion with duodenal switch. These interventions alter the digestive system to reduce caloric intake, nutrient absorption, or both, promoting significant and sustained weight loss. Beyond weight reduction, bariatric surgery has been shown to improve or resolve obesity-related comorbidities, including type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, and cardiovascular diseases. Patient selection is critical and involves a multidisciplinary team, including surgeons, endocrinologists, dietitians, and psychologists, to ensure optimal outcomes. Preoperative assessment focuses on identifying potential surgical risks, nutritional deficiencies, and psychological readiness. Postoperative care is equally important, with long-term follow-up for nutritional monitoring, physical activity guidance, behavioral therapy, and management of potential complications. Recent research explores minimally invasive techniques, enhanced recovery protocols, and personalized surgical approaches based on metabolic and genetic profiling. Bariatric surgery represents a transformative option in obesity medicine, providing not only weight reduction but also a significant improvement in quality of life and long-term health outcomes.

Track 05: Obesity Prevention

Obesity prevention is a cornerstone of public health, aiming to reduce the incidence of obesity before it occurs. Preventive strategies target dietary habits, physical activity, behavioral patterns, and socio-environmental factors that influence weight gain. Early-life interventions, including maternal nutrition, breastfeeding promotion, and healthy complementary feeding, play a crucial role in shaping lifelong metabolic health. School-based programs, community initiatives, and workplace wellness campaigns are effective in promoting healthy eating and active lifestyles. Policy measures, such as taxation on sugar-sweetened beverages, food labeling regulations, and urban planning that encourages physical activity, further support population-level prevention. Education and awareness campaigns are critical to empower individuals to make informed choices about nutrition and exercise. Prevention strategies must also address social determinants of health, including income, cultural practices, and access to healthcare, as these factors strongly influence obesity risk. By focusing on prevention, healthcare systems can reduce the burden of obesity-related diseases, lower healthcare costs, and improve population health outcomes. Research in obesity prevention explores behavioral interventions, community engagement, and the role of digital health tools in promoting sustainable lifestyle changes.

Track 06: Role of Steroids and Hormones in Obesity

Hormones and steroids play a pivotal role in regulating body weight, appetite, energy expenditure, and fat distribution. Dysregulation of hormonal pathways is a major contributor to obesity and metabolic disorders. Key hormones involved include insulin, leptin, ghrelin, cortisol, thyroid hormones, and sex steroids such as estrogen and testosterone. Leptin resistance can impair appetite control, while excess cortisol due to chronic stress promotes visceral fat accumulation. Thyroid dysfunction can slow metabolism, contributing to weight gain, and imbalances in sex steroids influence fat distribution, particularly in women. Exogenous steroid use, such as corticosteroids, can also induce weight gain and metabolic complications. Understanding these hormonal influences is crucial for designing effective obesity interventions, including pharmacotherapy targeting hormonal pathways, lifestyle modifications, and personalized nutritional strategies. Clinical evaluation often includes hormonal profiling to identify endocrine disorders contributing to obesity. Research in this area continues to uncover novel mechanisms and potential therapeutic targets, enabling more precise and effective management of obesity and its associated metabolic complications.

Track 07: Liposuction and Weight Loss Treatments

Liposuction is a cosmetic surgical procedure aimed at removing localized fat deposits to improve body contour, rather than treating systemic obesity. It is often used in combination with lifestyle interventions for patients seeking aesthetic improvement. Techniques such as tumescent liposuction, ultrasound-assisted liposuction, and laser-assisted liposuction allow for precise fat removal with minimal invasiveness. While liposuction can enhance body image and self-esteem, it does not directly address the metabolic complications of obesity, emphasizing the importance of combining it with diet, exercise, and behavioral modification. Emerging non-surgical treatments, including cryolipolysis, radiofrequency therapy, and injection lipolysis, offer less invasive options for localized fat reduction. These approaches are increasingly popular due to shorter recovery times and minimal complications. Patient selection and realistic expectations are essential to achieve optimal outcomes. Research is ongoing to evaluate long-term results, the metabolic impact of fat removal, and integration with other obesity management strategies. A comprehensive approach ensures that cosmetic procedures complement broader weight management goals.

Track 08: Obesity and Weight Loss

Weight loss is a primary goal in the management of obesity, aiming to reduce body fat, improve metabolic health, and prevent associated diseases. Effective weight loss strategies combine lifestyle modification, dietary interventions, physical activity, behavioral therapy, pharmacotherapy, and, in selected cases, surgical interventions. Caloric restriction, macronutrient balance, and portion control are fundamental nutritional approaches. Regular physical activity enhances energy expenditure, supports lean muscle mass, and improves cardiovascular health. Behavioral strategies, such as goal setting, self-monitoring, and motivational counseling, help individuals adopt and maintain healthy habits. Pharmacological options, including appetite suppressants and metabolic modulators, are used for patients who struggle to achieve weight loss through lifestyle changes alone. Bariatric surgery is reserved for patients with severe obesity or those with obesity-related comorbidities. Successful weight loss requires personalized, sustainable approaches rather than short-term diets. Research emphasizes the importance of addressing underlying metabolic, hormonal, and psychological factors to prevent weight regain and improve long-term health outcomes.

Track 09: Obesity Causes

Obesity is a multifactorial condition resulting from the interplay of genetic, environmental, behavioral, and hormonal factors. Excessive caloric intake, sedentary lifestyles, and poor dietary habits are primary contributors. Genetic predisposition can influence appetite regulation, energy expenditure, and fat distribution, making some individuals more susceptible to weight gain. Hormonal imbalances, including insulin resistance, leptin resistance, and thyroid dysfunction, further complicate weight regulation. Environmental factors such as urbanization, high-calorie food availability, and socioeconomic status play a significant role. Psychological factors, including stress, emotional eating, and sleep deprivation, also contribute to obesity. Chronic use of certain medications, such as steroids, antipsychotics, and some antihypertensives, can lead to weight gain. Understanding the underlying causes is essential for developing effective prevention and treatment strategies. Comprehensive interventions must address lifestyle, behavioral, hormonal, and environmental factors to achieve sustainable weight management. Research continues to identify new genetic markers, metabolic pathways, and environmental influences to better predict and prevent obesity.

Track 10: Current Research on Obesity

Obesity research focuses on understanding the complex mechanisms underlying excessive fat accumulation and associated health risks. Current studies investigate genetic and epigenetic factors, hormonal regulation, gut microbiota influence, and neuroendocrine pathways involved in appetite and energy balance. Clinical trials explore novel pharmacological treatments, including appetite suppressants, metabolic enhancers, and combination therapies targeting multiple pathways. Lifestyle interventions, dietary strategies, and exercise programs are continuously evaluated to optimize efficacy and adherence. Research also emphasizes the prevention of obesity in children and adolescents, as early intervention can reduce lifelong health complications. Advanced technologies, such as metabolomics, proteomics, and imaging techniques, are being used to identify biomarkers for obesity risk, progression, and response to therapy. Public health research examines the impact of social, economic, and environmental factors on obesity prevalence and evaluates community-based prevention programs. Collaborative global research initiatives aim to develop evidence-based strategies to reduce obesity-related morbidity and mortality worldwide.

Track 11: Childhood Obesity and Nutrition

Childhood obesity is a growing public health concern with long-term health implications. Excess body weight during childhood increases the risk of type 2 diabetes, cardiovascular diseases, metabolic syndrome, and psychosocial problems in adulthood. Poor dietary habits, including high consumption of sugar-sweetened beverages, fast food, and processed snacks, combined with sedentary behavior, are major contributors. Genetic predisposition, parental obesity, and early-life nutrition, including breastfeeding and complementary feeding practices, play a significant role in shaping a child’s metabolic profile. Effective management involves a combination of nutritional education, healthy meal planning, increased physical activity, and behavioral modification. Schools and community programs can provide structured interventions to promote healthy eating and active lifestyles. Family involvement is crucial, as parents influence food choices, activity levels, and attitudes toward health. Public health policies supporting healthy school meals, food labeling, and awareness campaigns contribute to prevention efforts. Research continues to explore the role of gut microbiota, nutrient composition, and early metabolic programming in childhood obesity. A multidisciplinary approach involving pediatricians, dietitians, psychologists, and educators is essential to achieve sustainable outcomes and prevent obesity-related complications in later life.

Track 12: Dietary and Lifestyle Changes

Dietary and lifestyle changes are foundational to obesity management, focusing on sustainable behavior modification rather than short-term dieting. A balanced, nutrient-rich diet that emphasizes whole grains, fruits, vegetables, lean proteins, and healthy fats supports weight reduction while improving metabolic health. Reducing the intake of added sugars, refined carbohydrates, and processed foods is essential to prevent further weight gain. Portion control, meal timing, and mindful eating strategies enhance adherence to dietary plans. Regular physical activity, including aerobic exercise, strength training, and flexibility exercises, promotes energy expenditure, preserves lean muscle mass, and improves cardiovascular and metabolic health. Behavioral interventions, such as goal setting, self-monitoring, stress management, and motivational counseling, support long-term lifestyle changes. Emerging approaches, including plant-based diets, intermittent fasting, and Mediterranean dietary patterns, have shown benefits in weight management and metabolic outcomes. Integration of technology, such as wearable fitness trackers, mobile health applications, and telemedicine, provides personalized guidance and continuous monitoring. Effective dietary and lifestyle interventions require individualized plans, continuous support, and ongoing evaluation to ensure sustainable results and prevent weight regain.

Track 13: Non-Surgical Treatment for Obesity

Non-surgical treatment options for obesity focus on achieving sustainable weight loss through lifestyle modification, pharmacotherapy, and behavioral interventions. Lifestyle approaches involve dietary changes, increased physical activity, and behavioral strategies to modify eating habits and energy expenditure. Personalized nutrition plans, portion control, and meal timing are combined with regular aerobic and resistance exercises to improve body composition and metabolic health. Pharmacotherapy may be recommended for patients with severe obesity or comorbidities, including medications that suppress appetite, enhance metabolism, or reduce fat absorption. Behavioral therapy, including cognitive behavioral therapy and motivational interviewing, addresses emotional eating, stress management, and adherence to treatment plans. Non-surgical approaches require continuous support, monitoring, and follow-up to prevent weight regain. Research into new pharmacological agents, combination therapies, and innovative digital tools is expanding the scope of effective non-surgical interventions. Multidisciplinary care, involving dietitians, psychologists, endocrinologists, and exercise specialists, ensures comprehensive management tailored to each patient’s unique needs, emphasizing long-term health outcomes rather than rapid weight loss.

Track 14: Anti-Obesity Drugs

Pharmacological therapy plays a critical role in managing obesity, especially for individuals who struggle with lifestyle interventions alone. Anti-obesity drugs target various pathways involved in appetite regulation, energy expenditure, and nutrient absorption. Commonly used medications include appetite suppressants, lipase inhibitors, and metabolic enhancers, each with specific mechanisms and indications. Drugs such as orlistat reduce fat absorption, while agents like GLP-1 receptor agonists regulate appetite and improve insulin sensitivity. Pharmacotherapy is often combined with lifestyle modifications, including dietary adjustments, increased physical activity, and behavioral therapy, to maximize effectiveness. Proper patient selection, dose titration, and monitoring for adverse effects are essential to ensure safety and efficacy. Ongoing research explores novel pharmacological agents, combination therapies, and personalized medicine approaches based on genetic and metabolic profiles. Anti-obesity drugs can significantly improve weight loss outcomes, reduce comorbidities such as diabetes and cardiovascular diseases, and enhance quality of life. Clinicians must consider individual patient needs, comorbid conditions, and long-term adherence when prescribing pharmacotherapy for obesity management.

Track 15: Diabetes, Endocrinology and Obesity

Obesity is closely linked to endocrine and metabolic disorders, most notably type 2 diabetes. Excess body fat contributes to insulin resistance, impaired glucose metabolism, and chronic inflammation, leading to metabolic dysfunction. Adipose tissue acts as an endocrine organ, releasing hormones and cytokines that influence appetite, energy balance, and insulin sensitivity. Obesity also affects thyroid function, sex hormones, and cortisol regulation, further complicating metabolic health. Effective management of obesity in patients with diabetes or endocrine disorders requires an integrated approach that combines lifestyle interventions, pharmacotherapy, and close medical monitoring. Nutritional strategies focusing on low-glycemic diets, caloric restriction, and balanced macronutrients support glucose control and weight reduction. Physical activity enhances insulin sensitivity, cardiovascular health, and energy expenditure. Emerging therapies targeting specific hormonal pathways and metabolic regulators are under investigation to optimize outcomes. Collaboration between endocrinologists, diabetologists, dietitians, and behavioral specialists is essential to provide individualized care. Understanding the bidirectional relationship between obesity and endocrine disorders helps clinicians prevent complications, improve patient quality of life, and achieve sustainable weight management.

Track 16: Obesity and Weight Management

Weight management is central to addressing obesity and improving overall health outcomes. Effective strategies combine lifestyle modification, behavioral interventions, pharmacotherapy, and, when appropriate, surgical procedures. Lifestyle interventions include balanced nutrition, regular physical activity, and sustainable dietary changes. Behavioral strategies such as self-monitoring, goal setting, motivational counseling, and stress management support adherence to weight management programs. Pharmacological options assist patients struggling with significant weight loss challenges, while bariatric surgery provides long-term solutions for severe obesity. Personalized approaches that consider genetics, metabolic status, and comorbid conditions enhance the success of weight management interventions. Regular monitoring, follow-up, and multidisciplinary care involving dietitians, psychologists, and medical specialists ensure sustained weight reduction and prevention of relapse. Emerging tools, including digital health applications, telemedicine, and wearable devices, provide real-time feedback and individualized guidance. Research in weight management focuses on optimizing intervention strategies, understanding mechanisms of weight regain, and developing evidence-based, patient-centered programs. Successful weight management improves metabolic health, reduces comorbidities, and enhances overall well-being.

Track 17: Clinical Obesity

Clinical obesity refers to obesity diagnosed and managed within a medical framework, considering comorbidities, severity, and individual patient needs. Assessment involves evaluating body mass index, waist circumference, metabolic parameters, and associated health risks. Clinical management emphasizes evidence-based interventions, including dietary modifications, physical activity, behavioral therapy, pharmacotherapy, and surgical options. Risk stratification and individualized treatment planning are essential to address specific metabolic, cardiovascular, and psychological concerns. Obesity clinics often employ multidisciplinary teams of physicians, dietitians, psychologists, and exercise specialists to provide comprehensive care. Ongoing monitoring and follow-up are crucial for preventing weight regain and managing chronic health complications. Clinical research continues to investigate new diagnostic tools, biomarkers, and treatment modalities to improve patient outcomes. Early intervention, personalized care, and integration of lifestyle, medical, and surgical therapies enhance the efficacy of clinical obesity management. Emphasizing patient education, motivation, and adherence ensures sustainable results and improved quality of life.

Track 18: Diet & Nutrition

Diet and nutrition are fundamental components of obesity prevention and treatment. A balanced, nutrient-dense diet supports weight loss, improves metabolic health, and reduces the risk of obesity-related comorbidities. Dietary strategies include caloric restriction, macronutrient optimization, portion control, and meal planning tailored to individual needs. Plant-based diets, Mediterranean diets, and low-carbohydrate approaches have demonstrated effectiveness in weight management. Nutritional counseling focuses on promoting healthy eating behaviors, reducing consumption of processed foods, and encouraging mindful eating practices. Integration of physical activity, behavioral strategies, and lifestyle modification enhances dietary adherence and long-term success. Emerging research examines nutrigenomics, personalized nutrition, and microbiome-based dietary interventions to optimize metabolic outcomes. Education on sustainable dietary habits, food labeling, and awareness of hidden sugars and fats empowers individuals to make informed choices. Collaboration with dietitians, healthcare professionals, and community programs ensures that dietary interventions are practical, evidence-based, and tailored to individual patient goals.

Track 19: Obesity and Metabolic Diseases

Obesity is a major risk factor for metabolic diseases, including type 2 diabetes, dyslipidemia, hypertension, and metabolic syndrome. Excess adipose tissue promotes insulin resistance, systemic inflammation, and hormonal imbalance, disrupting normal metabolic homeostasis. The interplay between obesity and metabolic diseases increases the risk of cardiovascular complications, non-alcoholic fatty liver disease, and renal disorders. Effective management requires a comprehensive approach combining lifestyle modifications, pharmacotherapy, and close monitoring of metabolic parameters. Nutritional interventions focusing on low-glycemic diets, calorie control, and balanced macronutrient intake improve metabolic outcomes. Regular physical activity enhances glucose metabolism, lipid profiles, and cardiovascular health. Early detection and intervention are critical to prevent progression and complications. Research in this field investigates novel therapies, biomarkers for metabolic risk assessment, and personalized treatment approaches. Multidisciplinary care, involving endocrinologists, dietitians, and behavioral specialists, ensures optimal management of obesity-related metabolic diseases. Understanding the relationship between obesity and metabolic disorders is essential for reducing morbidity and improving long-term patient outcomes.

Track 20: Genetics and Epigenetics of Obesity

Obesity is strongly influenced by genetic and epigenetic factors that affect metabolism, appetite regulation, fat storage, and energy expenditure. Genetic variations, including single nucleotide polymorphisms and gene mutations, can predispose individuals to increased fat accumulation and metabolic disorders. Key genes involved include those regulating leptin, melanocortin, and insulin signaling pathways. Epigenetic modifications, such as DNA methylation, histone modification, and non-coding RNA regulation, can influence gene expression in response to environmental factors, diet, and lifestyle. These changes may occur during critical developmental periods, including prenatal and early childhood stages, affecting long-term obesity risk. Research in this field focuses on identifying genetic markers, understanding gene-environment interactions, and developing personalized treatment strategies. Knowledge of genetic and epigenetic contributions enables targeted interventions, including tailored nutritional plans, lifestyle modifications, and pharmacotherapy, improving weight management outcomes. Integration of genomics into clinical practice holds promise for precision medicine approaches to obesity prevention and treatment.

Track 21: Obesity & Cancer

Obesity is recognized as a major risk factor for several types of cancer, including breast, colorectal, pancreatic, endometrial, and liver cancers. Excess adipose tissue creates a pro-inflammatory environment, increases insulin and insulin-like growth factor levels, and alters hormone metabolism, promoting tumor growth and progression. Obesity also influences cancer prognosis, treatment efficacy, and survival rates. Preventive strategies, including weight management, healthy nutrition, and physical activity, are critical in reducing cancer risk. Understanding molecular mechanisms, such as chronic inflammation, oxidative stress, and adipokine signaling, is essential for developing targeted therapies. Clinical management of obese cancer patients requires multidisciplinary care to address treatment challenges, including dosing considerations, surgical risks, and comorbidity management. Research continues to explore the relationship between obesity and tumor biology, the impact of weight loss interventions on cancer outcomes, and potential therapeutic targets. Raising awareness about the link between obesity and cancer is vital for public health education and prevention strategies.

Track 22: Obesity and Eating Disorders

Obesity and eating disorders often coexist, presenting complex clinical challenges. Conditions such as binge eating disorder, night eating syndrome, and emotional eating contribute to excessive caloric intake and weight gain. Psychological factors, including stress, depression, anxiety, and body image dissatisfaction, influence eating behaviors and complicate obesity management. Early recognition and comprehensive assessment are essential to provide effective interventions. Treatment involves a multidisciplinary approach combining nutritional counseling, behavioral therapy, psychotherapy, and pharmacological support when necessary. Cognitive behavioral therapy, mindfulness-based interventions, and motivational interviewing are effective in addressing maladaptive eating patterns. Understanding the underlying psychological and biological mechanisms helps clinicians develop personalized treatment plans. Public health initiatives focusing on awareness, stigma reduction, and early intervention can prevent progression of eating disorders and associated obesity. Research continues to explore neurobiological pathways, genetic predisposition, and innovative therapies to manage this complex interplay effectively.

Track 23: Physical Activity, Exercise & Kinesiology

Physical activity and structured exercise are cornerstone interventions in obesity management, promoting energy expenditure, muscle mass preservation, and metabolic health. Aerobic exercise improves cardiovascular fitness, enhances glucose metabolism, and reduces visceral fat, while resistance training builds lean muscle and supports long-term weight maintenance. Kinesiology studies body movement to optimize exercise protocols, prevent injury, and improve functional capacity. Exercise programs should be tailored to individual capabilities, comorbidities, and personal goals, integrating both structured workouts and lifestyle activity. Behavioral strategies, such as goal setting, self-monitoring, and motivational support, enhance adherence. Physical activity also positively affects mental health by reducing stress, anxiety, and depression, which are often associated with obesity. Research highlights the benefits of high-intensity interval training, circuit training, and multimodal exercise approaches in obesity management. Incorporating technology, including wearable devices and fitness applications, enables personalized monitoring and progress tracking. Comprehensive exercise programs form an integral component of multidisciplinary obesity treatment plans.

Track 24: Advanced Treatment for Obesity

Advanced obesity treatments combine medical, surgical, and innovative approaches to achieve sustainable weight loss and metabolic improvement. Bariatric surgery, including sleeve gastrectomy, gastric bypass, and adjustable gastric banding, offers long-term solutions for severe obesity. Pharmacotherapy, utilizing appetite suppressants and metabolic enhancers, complements lifestyle interventions. Emerging therapies, such as endoscopic procedures, metabolic devices, and gut microbiota modulation, expand treatment options. Personalized treatment planning based on genetics, metabolism, comorbidities, and behavioral assessment enhances outcomes. Preoperative evaluation, perioperative care, and postoperative monitoring are critical for safety and efficacy. Multidisciplinary care teams involving surgeons, dietitians, psychologists, and exercise specialists ensure comprehensive management. Research explores minimally invasive techniques, combination therapies, and long-term strategies to prevent weight regain. Advanced treatments aim not only to reduce weight but also to improve metabolic health, quality of life, and obesity-related disease outcomes, representing the forefront of obesity medicine innovation.

Track 25: Obesity and Chronic Diseases

Obesity is a significant risk factor for numerous chronic diseases, including cardiovascular disease, type 2 diabetes, hypertension, liver disease, kidney disorders, respiratory complications, and osteoarthritis. Excess adipose tissue drives systemic inflammation, hormonal dysregulation, and metabolic disturbances that exacerbate chronic disease progression. Early identification and management of obesity can prevent or delay the onset of chronic conditions and improve overall health outcomes. Comprehensive care involves lifestyle interventions, pharmacotherapy, surgical options, and continuous monitoring. Multidisciplinary approaches address both weight reduction and disease management, including cardiovascular risk reduction, glycemic control, and musculoskeletal health. Research emphasizes the role of personalized strategies, integration of technology, and community-based interventions in reducing the burden of chronic diseases associated with obesity. Patient education, adherence, and support are essential for successful long-term outcomes.

Track 26: Yoga and Naturopathy

Yoga and naturopathy offer complementary approaches for obesity management by promoting physical activity, stress reduction, and holistic well-being. Yoga improves flexibility, muscle strength, and cardiovascular health while reducing stress, emotional eating, and cortisol levels. Breathing exercises, meditation, and mindfulness practices enhance mental health and support behavioral change in weight management. Naturopathy focuses on natural therapies, including dietary adjustments, detoxification, herbal remedies, and lifestyle modification, aiming to restore balance and optimize metabolic health. Integrating these approaches with conventional medical treatments can enhance weight loss outcomes and improve overall physical and mental well-being. Research supports yoga and naturopathy as effective adjuncts in obesity prevention and treatment, particularly for long-term maintenance and stress-related weight issues. Multidisciplinary collaboration ensures these therapies complement conventional medical interventions safely and effectively.

Track 27: Obesity and Cardiovascular Diseases

Obesity significantly increases the risk of cardiovascular diseases, including coronary artery disease, heart failure, arrhythmias, and hypertension. Excess adipose tissue contributes to systemic inflammation, endothelial dysfunction, insulin resistance, and dyslipidemia, accelerating atherosclerosis and cardiac complications. Weight management through lifestyle interventions, pharmacotherapy, and surgical approaches reduces cardiovascular risk and improves prognosis. Nutritional strategies, regular physical activity, and behavioral interventions are essential components of cardiovascular risk reduction. Early screening for obesity-related cardiovascular markers and comorbidities allows timely intervention and personalized care planning. Research continues to explore the pathophysiological links between obesity and heart disease, novel pharmacological therapies, and preventive strategies. Integrating cardiology and obesity medicine ensures comprehensive patient care, improving both weight management outcomes and cardiovascular health.

Market Analysis Report

The global obesity medicine market is experiencing remarkable growth, driven by the rising global prevalence of obesity and increasing awareness of its severe health implications such as diabetes, cardiovascular disease, and metabolic disorders. According to recent reports, the global obesity treatment market was valued at approximately USD 15.9 billion in 2024 and is projected to reach nearly USD 60.5 billion by 2030, growing at a compound annual growth rate (CAGR) of about 22%. This growth is primarily attributed to the growing demand for effective weight management solutions, including pharmacological treatments, bariatric surgeries, and lifestyle-based interventions. The global recognition of obesity as a chronic disease has also shifted public health priorities, encouraging greater investment in research, healthcare infrastructure, and preventive measures.

Technological advancements and pharmaceutical innovations are further fueling market expansion. The introduction of GLP-1 receptor agonists, such as semaglutide and liraglutide, has revolutionized obesity treatment by offering effective and safe pharmacological options. This drug class accounted for more than 80% of the anti-obesity drug market share in 2024, highlighting its dominant role. The anti-obesity drug segment alone was valued at USD 6.6 billion in 2023 and is expected to surge to USD 77 billion by 2030. Additionally, the adoption of digital health tools—such as telemedicine, wearable devices, and personalized nutrition platforms—has enhanced patient engagement and treatment adherence. These integrated technological solutions are transforming obesity management from short-term interventions into long-term, data-driven care strategies.

Regionally, North America remains the market leader due to its advanced healthcare system, strong regulatory support, and high obesity prevalence. However, Asia-Pacific is emerging as the fastest-growing region, fueled by increasing urbanization, changing lifestyles, and government initiatives promoting preventive healthcare. Analysts predict that over 16 new obesity drugs will enter the market by 2029, potentially pushing the industry’s value to USD 200 billion by 2031. The future of obesity medicine will be shaped by a combination of pharmaceutical innovation, digital transformation, and multidisciplinary collaboration. As the market continues to expand, it holds the potential to significantly reduce the global burden of obesity-related diseases and improve quality of life for millions worldwide.

Obesity Associations and Societies:

• The Obesity Society
• Association for the Study of Obesity
• World Obesity Federation
• British Obesity Society
• All India Association for Advancing Research in Obesity
• European Association for the Study of Obesity: EASO
• American Obesity Association (AOA) – Obesity
• Australian and New Zealand Obesity Society (ANZOS)
• American Society for Metabolic and Bariatric Surgery
• American Heart Association
• British Obesity & Metabolic Surgery Society
• American Society of Bariatric Physicians
• American Board of Obesity Medicine
• American Association of Clinical Endocrinologists
• JASSO | Japan Society for the Study of Obesity
• International Federation for the Surgery of OBESITY AND METABOLIC DISORDERS (IFSO)
• Obesity Management Association
• Obesity Foundation India
• The Society for Obesity and Bariatric Anesthesia
• International Society for the Perioperative Care of Obese Patients
• American Journal of Clinical Nutrition
• American Thoracic Society
• Saudi Arabia Society of Metabolic and Bariatric Medicine
• Malaysian Association for the Study of Obesity (MASO)
• Obesity and Metabolic Surgery Society of Singapore

Explore the latest developments and emerging trends in obesity research and treatment.
Meet renowned global experts and dedicated healthcare professionals.
Present your research work and receive international recognition.
Earn accredited continuing medical education (CME) points.
Gain continuing professional development (CPD) credits.
Participate in interactive workshops and informative scientific sessions.
Receive an official certificate of participation with CME/CPD hours indicated.
Build valuable collaborations and expand your professional network.
Enhance your qualifications and strengthen your career profile.
Discover new anti-obesity drugs and advanced therapeutic approaches.
Learn about innovations in nutrition and lifestyle management.
Visit exhibitor booths displaying the latest medical technologies.
Receive an internationally recognized participation certificate.

Accreditation Information

The 20th International Conference on Obesity Medicine, scheduled on January 26–27, 2026 in Rome, Italy, will be officially accredited for Continuing Medical Education (CME) and Continuing Professional Development (CPD) points. The scientific program, including keynote lectures, oral presentations, panel discussions, and workshops, will undergo review and approval by internationally recognized accreditation authorities to ensure compliance with global educational and clinical standards.

Participants attending the full two-day conference will be eligible to earn 15–20 CME/CPD credits, depending on the total number of sessions attended and participation in accredited learning activities. These credits can be applied toward medical license renewal, academic advancement, and professional certification requirements. Each registered delegate will receive an official certificate of participation specifying the number of accredited hours earned during the event.

This accreditation reinforces the conference’s commitment to promoting high-quality, evidence-based medical education. By participating, healthcare professionals will enhance their clinical knowledge, expand their professional competencies, and stay informed about the latest innovations in obesity prevention, diagnosis, and treatment, contributing to global excellence in obesity medicine.

Abstract Submission
Submit your research or case study for the 20th International Conference on Obesity Medicine. Share your findings with global experts and gain recognition in the field of obesity prevention and treatment. All abstracts will undergo a peer-review process for presentation approval.

Submit Your Abstract Here: https://obesitymedicine.conferenceseries.com/abstract-submission.php

Registration & Book Your Slot: https://obesitymedicine.conferenceseries.com/registration.php

For Inquiries

If you have any questions regarding the 20th International Conference on Obesity Medicine, abstract submissions, registration, or participation, please reach out to us:

Email: contact@speakermeeting.com

Our team will respond promptly to assist you with all your conference-related queries.

Past Conference Report

OBESITY MEDICINE 2025

Welcome to the 19th International Conference on Obesity Medicine
October 06–07, 2025 | London, UK
Theme: AI in Obesity Diagnosis and Early Intervention

We are pleased to welcome you to the 19th International Conference on Obesity Medicine, taking place in the historic and vibrant city of London, UK, on October 06–07, 2025. This premier event is dedicated to addressing the complex and evolving challenges of obesity and its medical management, with a special focus this year on the transformative role of artificial intelligence in diagnosis and early intervention.

As obesity rates continue to rise globally, the importance of innovation in prevention, diagnosis, and treatment has never been more critical. Obesity medicine is at the forefront of improving public health, and this conference serves as a vital platform for researchers, clinicians, and academics to share insights, explore new technologies, and foster multidisciplinary collaboration.

Over the course of two days, attendees will engage in discussions on cutting-edge research, AI-driven healthcare solutions, and evidence-based clinical practices. Our dynamic program features keynote addresses, expert-led workshops, and interactive sessions designed to inspire dialogue and drive progress.

We invite you to join us on this exciting journey of exploration and knowledge exchange as we work together to shape the future of obesity medicine and enhance global health outcomes through innovation and collaboration.